Navigation Links
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
Date:8/6/2009

BRISBANE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the second quarter and six months ended June 30, 2009. InterMune reported a net loss for the second quarter of 2009 of $36.7 million, or $0.81 per share, compared with a net loss of $29.6 million, or $0.76 per share, in the second quarter of 2008.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "The last several months have been exceptionally productive for InterMune and the coming months promise to be even more so. Regarding pirfenidone, we have made excellent progress on the preparation of our New Drug Application (NDA) for pirfenidone which we now expect to submit in the fourth quarter. It has taken more time than we anticipated to integrate the advice of a host of external expert advisors and to take every possible step to develop the strongest possible file that positions us for potential approval in the first review cycle. Our Marketing Authorization Application (MAA) is also progressing very well; we had a successful pre-submission meeting with the EMEA in July and we expect to submit the MAA for pirfenidone in the first quarter of 2010."

Mr. Welch continued, "Regarding ITMN-191 (R7227), we announced exciting news today on several important aspects of the program, specifically: the successful completion of six-month and nine-month chronic toxicology studies in rats and monkeys, respectively which clear the way for our Phase 2 and Phase 3 clinical programs; our expectation that our partner Roche will enroll the first patient in our Phase 2b study of ITMN-191 in combination with standard of care in August; our plans to start a Phase 1b MAD study of ITMN-191 in combination with low dose ritonavir in HCV patients in the thi
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. InterMune to Release Second Quarter Financial Results on August 6
2. InterMune to Present at Goldman Sachs Healthcare Conference
3. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
4. InterMune to Release First Quarter Financial Results on April 30
5. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
6. InterMune to Present at Canaccord Adams Hepatitis C Conference
7. InterMune to Present at Citis 4th Annual Biotech Day
8. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
9. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
10. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
11. InterMune Announces Issuance of U.S. Patent for ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 As ... manage numerous projects in the MENA region during 2014 ... have a preferred provider agreement with DZS to manage ... MENA region,” said Global VP of R&D and President ... has developed excellent operational practices with a focus on ...
(Date:7/23/2014)... RICHMOND, Calif., July 23, 2014  Sangamo BioSciences, Inc. ... quarter 2014 financial results and accomplishments. ... reported a consolidated net loss of $7.0 million, or ... $5.5 million, or $0.10 per share, for the same ... Company had cash, cash equivalents, marketable securities and interest ...
(Date:7/23/2014)... -- Think Drinks are a neuroscience-backed drink regimen developed ... are the first functional focus beverage to give users ... to the temporary fix associated with energy drinks. truBrain ... 2014, with hopes to raise $50,000 over the course ... http://photos.prnewswire.com/prnh/20140723/129697 Think Drinks were designed ...
Breaking Biology Technology:Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2
... starting in Appleton, Wisconsin. The Hive brings together ... who live in the Fox Valley. , ,Hive ... Bob Pankratz insist that this high-tech networking event ... Hive is devoted to helping entrepreneurs network amongst ...
... Accessibility technology developed by the University of ... help people use the United States Postal Services automated ... goal of our work was to find a simple ... there that would work across disabilities, said Gregg Vanderheiden, ...
... Commerce, said on Friday that he would resign from his post ... Quarles & Bradys Milwaukee office. , ,Nettles has served in ... returning to the firm he worked at before Doyle appointed him. ... a leader, a boss, and a friend, he said in a ...
Cached Biology Technology:A new high-tech networking event buzzes in Appleton 2A new high-tech networking event buzzes in Appleton 3UW Trace center makes sending packages accessible to all 2Secretary Nettles leaving Commerce for law practice 2Secretary Nettles leaving Commerce for law practice 3
(Date:7/24/2014)... researchers and patients have hoped that embryonic stem cells ... bodycould provide insight into numerous diseases perhaps even be ... by the inability to transfer research and tools from ... because human ESCs are "primed" and slightly less plastic ... Powell, and Haoyi Wang, who are scientists in the ...
(Date:7/24/2014)... is currently conducting research into the potato genes that ... by a reduction in rainfall and increased extremes of ... most resistant genes in order to create new potato ... research is also seeking to find out how the ... greater drought and higher and lower temperatures. , This ...
(Date:7/24/2014)... by the University of York has carried out the ... Indian Ocean. , The results, reported in the ... in the management of marine protected areas, with almost ... in the region now under local community stewardship. ... seas and coasts designed to protect wildlife from damage ...
Breaking Biology News(10 mins):Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2Western Indian Ocean communities play vital role in conservation 2
... 21, 2012)-- An assistant professor at Sam Houston ... to unlock the mysteries surrounding the role that ... antisocial behavior. "Biosocial research is a multi-disciplinary ... Boutwell. "It involves aspects of behavioral genetics, neuroscience, ...
... Purdue University researchers revealed how a mutation in a ... the death of neurons in Parkinson,s disease, possibly opening ... disorder. Fred Regnier, the J.H. Law Distinguished Professor ... medicinal chemistry and molecular pharmacology, led the team that ...
... Stanford, CA Along with photosynthesis, the plant cell ... plants apart from animals. A structural molecule called cellulose ... Cellulose is synthesized in a semi-crystalline state that is ... but the mechanisms controlling its crystallinity are poorly understood. ...
Cached Biology News:Are there biosocial origins for antisocial behavior? 2Purdue researchers reveal role of protein mutation in Parkinson's disease 2Purdue researchers reveal role of protein mutation in Parkinson's disease 3Plant toughness: Key to cracking biofuels? 2Plant toughness: Key to cracking biofuels? 3